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Background: Fournier's gangrene (FG) is a rapidly progressive necrotizing infection of the perineal and
genital fascia. The disease is always associated with high morbidity and mortality if diagnosed late and
treated improperly.
Purpose: This paper analyzed the epidemiology of FG, and clariﬁed the treatment strategy of FG of
different origins and prognosis.
Methods: From January 2007 to December 2015, 60 patients with FG were treated at the Chi Mei Medical
Center (Tainan, Taiwan). Their medical records were reviewed and analyzed.
Results: Sixty patients were identiﬁed: 50 (83.33%) men and 10 (16.66%] women who were aged 29e90
years (mean 59.6 ± 14.5 years). The most frequent systemic illness was diabetes mellitus (73.33%). The
location of FG was in the anorectal region in 21 (35.00%) patients, urogenital region in 25 (41.66%) pa-
tients, and dermatological region in 14 (23.33%) patients. The patients underwent from zero to nine
surgical debridements with an average of 3.1 surgical debridements. Septic shock was observed in 25
patients. All 14 patients who expired died of sepsis. The survival rates were better for patients who
underwent an early colostomy than for patients who underwent a delayed colostomy [20/21 (95.2%)
patients vs. 2/7 (22.2%) patients, respectively; p < 0.001]. Patients with septic shock who received hy-
perbaric oxygen therapy (HBO) had better survival rates than patients who did not have HBO [7/7 (100%)
vs. 4/18 (22.22%), respectively; p ¼ 0.0007].
Conclusion: Bacteremia and sepsis are major indicators of the mortality rate for FG. The cornerstones of
treatment are early diagnosis, aggressive resuscitation, broad-spectrum antibiotic therapy, early co-
lostomy, and prompt and repeated surgical intervention. Adjuvant HBO therapy led to higher survival
rates.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Fournier's gangrene (FG) is a rare necrotizing fasciitis with rapid
progression. It involves the genitals and perineum and is associated
with high morbidity and mortality.1 It often originates in the gen-
itals and quickly spreads from Buck's fascia to subcutaneous tissues
such as the scrotum, penis, perineum, and anterior abdominalogy Surgery, Department of
, Zhonghua Road, Yongkang
ociation. Published by Elsevier Tafascia.1,2 The most common bacteria are Enterobacteriaceae and
anaerobic bacteria such as Bacillus fragilis. Early clinical symptoms
include redness, swelling, heat, and pain, followed by progressive
pain, fever, and other symptoms of systemic toxicity (e.g., septic
shock).1,3
In 1992, the American College of Chest Physicians/Society of
Critical Care Medicine Consensus Conference deﬁned septic shock
as severe sepsis plus persistently low blood pressure after the
administration of intravenous ﬂuids.4 Septic shock can cause organ
dysfunction and death.5 The literature indicates that the mortality
rate of FG is highdup to 14e45%dwith higher mortality for the
diffuse type than for the local type.6 Early colostomy for FG of theiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
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tality rate.7,8 Delayed colostomy is deﬁned as a colostomy that is
created 2 days after the ﬁrst debridement.9
Fournier's gangrene usually causes local tissue hypoxia. The
infectious agents include aerobic and anaerobic gram-negative
bacilli. Hyperbaric oxygen (HBO) therapy has a bactericidal effect
on anaerobic infection caused by aerobic or anaerobic bacteria.
Hyperbaric oxygen therapy is widely and successfully used to treat
mixed infections by improving tissue perfusion, promoting angio-
genesis, increasing the oxygen level in tissues, and inhibiting the
production of toxins. These factors inhibit the growth of anaerobic
bacteria. It has an adjuvant role in the management of severe
Fournier's gangrene.10
2. Materials and methods
2.1. Study objective
The aim of the study was to investigate the epidemiology of FG,
effectiveness of treatment, and prognosis. The study provides in-
formation on the effectiveness of early diagnosis, aggressive sur-
gical debridement, and adjuvant HBO therapy on FG.
2.2. Methods
This study is a retrospective analysis of 60 patients diagnosed
with FG (ICD-9 codes 603.83 for men and 728.86 for women) in Chi
Mei Medical Center (Tainan, Taiwan) from January 2007 to
December 2012. We analyzed sex, age, comorbidities, clinical
symptoms, lab testing results, wound culture data, timing of
debridement, antibiotics use, treatment outcome, and prognosis.
The study was approved by the Institutional Review Board (IRB) of
Chi Mei Medical Center (IRB number, 10203-010). In 1995, Laor and
colleagues11 created the Fournier's gangrene severity index (FGSI).
It is composed of nine parameters: temperature, heart rate, respi-
ratory rate, serum sodium level, potassium level, creatinine level,
bicarbonate level, hematocrit, and leukocyte count. On admission,
the nine parameters were scored with values of 0e4, as described
in Table 1.
2.3. Statistical analysis
The data were stratiﬁed by the outcome of whether the patient
died or survived. Continuous datawere presented as the meanwith
standard deviation, and were compared between groups by using
the two-sample t test. Categorical datawere presented by the count
and percentage, and were compared by using the Chi-square test or
Fisher's exact test, as appropriate. To identify the predictors ofTable 1
Fournier's gangrene severity index.
Physiological variables High abnormal values
Point assignment 4þ 3þ 2þ 1þ
Body temperature (C) >41 39e40.9 d 38.5
Heart rate >180 140e179 110e139 d
Respiratory rate >50 35e49 d 25e
Serum sodium (mmol/L) >180 160e179 155e159 150
Serum potassium (mmol/L) >7 6e6.9 d 5.5e
Serum creatinine (mg/100 mL) >3.5 2e3.4 1.5e1.9 d
Hematocrit (%) >60 d 50e59.9 46e
Leukocytes (total/mm3  1000) >40 d 20e39.9 15e
Serum bicarbonate >52 41e51.9 d 32e
FGSI ¼ Fournier's gangrene severity index.survival, multivariable binary logistic regression analyses were
conducted. A difference was statistically signiﬁcant at p < 0.05. Data
analyses were performed by using SPSS version 17.0 software (SPSS
Inc., Chicago, IL, USA).
3. Results
3.1. Sex and age
Fournier's gangrene affects all ages and primarily men with a
male:female ratio of 10:1. The current study had 60 patients, which
included 50 men and 10 women. Their age ranged from 29 years to
90 years (mean age, 59.6 ± 14.5 years).
3.2. Clinical symptoms, complications, and laboratory results
Early clinical symptoms include redness, swelling, heat, pain
(100%), symptoms similar to cellulitis, and systemic reactions such
as high fever (i.e., body temperature > 38C). Fifty-seven (95%)
patients had a comorbidity. The most common comorbid diseases
were diabetes mellitus [44 (73.33%) patients], hypertension [25
(41.66%) patients], liver cirrhosis [4 (6.66%) patients], and end-stage
renal disease [ESRD; 7 (11.66%) patients].
3.3. The location and extent of injury
The primary origins of injury are summarized in Table 2, as
follows: dermatological [14 (23.33%) patients], anorectal [21 (35%)
patients], and urogenital [25 (41.66%) patients]. Fournier's
gangrene progressed to the groin, lower abdomen, and thigh in 12
patients. Necrotizing fasciitis can occur in any part of the body;
however, the limbs, abdominal wall and perineum are the most
common sites. Fournier's gangrene is an infection involving the
perineal region (Figures 1 and 2).
3.4. Bacteriology
Necrotic tissue or pus obtained from the wound during surgery
or at the bedside was sent for microbial culture and antibiotic
testing. For each of the 60 patients, the wounds were cultured, and
the species were cultured. The most commonly isolated organisms
were Escherichia coli in 21 patients, Enterococcus species in 16 pa-
tients, Viridans streptococcus in 15 patients, Klebsiella pneumoniae in
14 patients, and Staphylococcus species in eight patients; Proteus
species in seven patients; oxacillin-resistant Staphylococcus aureus
(ORSA) in six patients; and anaerobic bacteria such as Bacteroides
species in four patients, Clostridium perfringens in four patients,
Peptoniphilus species in four patients, and Fusobacterium species inNormal values Low abnormal values
0 1þ 2þ 3þ 4þ
e38.9 36e38.4 34e35.9 32e33.9 30e31.9 <29.9
70e109 d 56e69 40e54 <39
34 12e24 10e11 6e9 d <5
e154 130e149 d 120e129 111e119 <110
5.9 3.5e5.4 3e3.4 2.5e2.9 d <2.5
0.6e1.4 d <0.6 d d
49.9 30e45.9 d 20e29.9 d <20
19.9 3e14.9 d 1e2.9 d <1
40.9 22e31.9 d 18e21.9 15e17.9 <15
Table 2
Location of Fournier's gangrene.
Location No. of patient
Dermatological 14 (23.33%)
Anorectal 21 (35.00%)
Anal abscess 16
Ischiorectal abscess 5
Urogenital 25 (41.66%)
Scrotum 24
Penis 1
The data are based on 60 patients.
Table 3
Results of the bacteriologic culture (N ¼ 122).a
Microorganism Survived/died Total p
Aerobic culture
Enterococcus species 12/4 16 1.000
Enterobacter aerogenes 1/4 5 0.015*
Escherichia coli 15/6 21 1.000
Viridans streptococcus 10/5 15
Klebsiella pneumoniae 9/5 14
Proteus species 2/5 7 0.012*
Staphylococcus species 8/0 8 0.095
ORSA 2/4 6 0.038*
Pseudomonas aeruginosa 1/0 1 1.000
Acinetobacter baumannii 2/5 7
Morganella morganii 2/1 4 1.000
Anaerobic culture
Bacteroides species 3/1 4
Clostridium perfringens 4/0 4
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revealed that mortality was signiﬁcantly correlated with the
isolation of Enterobacter aerogenes, Proteus species, ORSA, and
Candida (p < 0.05; Table 3).Peptoniphilus species 4/0 4
Fusobacterium species 1/0 1
Candida 1/4 5 0.05*
*The p value is based on the Pearson's Chi-square test and Fisher's exact test.
ORSA ¼ oxacillin-resistant Staphylococcus aureus.
a The data are based on 122 cultures.3.5. Treatment and outcomes
All patients in this study were ﬁrst treated with broad-spectrum
antibiotics. The treatment was then adjusted according to the pa-
tient's clinical condition and culture results. Many studies prove
that early and sufﬁcient surgical debridement and fasciotomy
improve the survival rate. Complete surgical intervention includes
fasciotomy, drainage, and debridement of all necrotic tissue until
reaching healthy tissue. In the current study, 57 (95%) patients
received fasciotomy within 24 hours after admission. However,
fasciotomy alone is an insufﬁcient treatment. Repeated debride-
ment may be necessary. The number of surgical debridements the
patients underwent in this study varied from zero to nineFigure 1. Necrotizing fasciitis of the scrotum and perineum after serial debridement and hy
hospital stay was 58 days. A: Necrotizing fasciitis of the scrotum and perineum after serial d
reconstructive surgery.
Figure 2. Fournier's gangrene extends to the right inguinal area with substantial necrotic t
oxygen therapy. A: Necrosis extends to the right inguinal region with substantial necrotic tiss
C: Final appearance of right inguinal region after suture.debridements with an average of 3.1 debridements. Fournier's
gangrene requires different management strategies, depending on
the severity of the disease. Among the 44 survivors, eight patients
had a skin ﬂap, three patients had a skin graft, 19 patients under-
went wound closure surgery, and the remaining 14 patients healed
with dressing changes. The mortality rate was 26.7% (16/60
patients).perbaric oxygen therapy. The wound was reconstructed with a skin ﬂap. The patient's
ebridement. B: secondary debridement. C: Final appearance of the perianal region after
issue on the fascia and muscle layer status postextensive debridement and hyperbaric
ue on the fascia and muscle layer. B: good granulation after hyperbaric oxygen therapy.
Table 4
Factors related to the mortality of Fournier's gangrene.a
Factor No. of patients (%) Alive n (%) Mortality n (%) p OR (95%CI)
Age (y)
>55 39 25 (64.1) 14 (35.9) 0.034* 1.00
<55 21 19 (90.5) 2 (9.5) 5.32 (1.08e26.28)*
DM
Yes 44 32 (72.7) 12 (27.3) 1.000 1.13 (0.30e4.18)
No 16 12 (75.0) 4 (25.0) 1.00
HTN
Yes 25 16 (64.0) 9 (36.0) 0.167 2.25 (0.70e7.20)
No 35 28 (80.0) 7 (20.0) 1.00
LC
Yes 4 1 (25.0) 3 (75.0) 0.054* 9.92 (0.95e103.64)
No 56 43 (76.8) 13 (23.2) 1.00
ESRD
Yes 7 3 (42.9) 4 (57.1) 0.074 4.56 (0.89e23.24)
No 53 41 (77.4) 12 (22.6) 1.00
Septic shock
Present 25 11 (44.0) 14 (56.0) <0.001* 18.00 (2.18e148.38)*
Absent 35 33 (94.3) 2 (5.7) 1.0
Colostomy
Early 21 20 (95.2) 1 (4.8) <0.001* 0.14 (0.02e1.20)
Delayed 9 2 (22.2) 7 (77.8) 9.63 (1.64e56.37)*
No 30 22 (73.3) 8 (26.7) 1.00
HBO
Yes 12 12 (100.0) 0 (0.0) 0.025* d
No 48 32 (66.7) 16 (33.3) 1.00
Severity
Mild 46 37 (80.4) 9 (19.6) 0.024* 1.00 (ref.)
Severe 14 7 (50.0) 7 (50.0) 4.11 (1.15e14.73)
Location
Dermatological 14 10 (71.4) 4 (28.6) 0.6026 1.00 (ref.)
Anorectal 21 17 (80.9) 4 (19.1) 1.18 (0.28e4.93)
Urogenital 25 17 (68.0) 8 (32.0) 0.59 (0.12e2.89)
*The p value is based on the Pearson's Chi-square test and Fisher's exact test.
ARF ¼ acute renal failure; DM ¼ diabetes mellitus; ESRD ¼ end-stage renal disease; HBO ¼ hyperbaric oxygen; HTN ¼ hypertension; LC ¼ liver cirrhosis.
a The data are based on 60 cases. In the Fournier's gangrene severity index (FGSI), a FGSI score < 9 is mild and FGSI score  9 is severe.
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Thirty patients in the study had a diverting colostomy. Twenty-
one patients in the studywho had an early colostomy had a survival
rate of 95.2% (20/21 patients), compared to 22.2% (2/9 patients) for
patients who did not have a colostomy (Table 4). The number of
surgical debridement procedures and the need for diverting co-
lostomy did not have an effect on postoperativemortality. However,
delayed formation of a colostomy (>48 hours) increased the mor-
tality of patients with FG that required a stoma (p < 0.001).
3.7. Complications
Complications were septic shock in 25 (41.66%) patients,
disturbed consciousness in six (10%) patients, upperTable 5
Analysis of the distribution of patient survival, based on age, severity, and location.
No. of patients HBO
Survival n (%) Mortality n (%)
Age (y)
<55 21 8 (100.00) 0 (0.00)
>55 39 4 (100.00) 0 (0.00)
Severity
Mild 46 9 (100.00) 0 (0.00)
Severe 14 3 (100.00) 0 (0.00)
Location
Dermatological 14 4 (100.00) 0 (0.00)
Anorectal 21 4 (100.00) 0 (0.00)
Urogenital 25 4 (100.00) 0 (0.00)
HBO ¼ hyperbaric oxygen.gastrointestinal (UGI) bleeding in two (3.33%) patients, and skin
necrosis in 14 (23.33%) patients.3.8. Hyperbaric oxygen therapy
Hyperbaric oxygen therapy has been used as adjuvant treatment
for infectious diseases. Twelve (20%) patients who had HBO therapy
in the study had a survival rate of 100% (12/12 patients), compared
to 66.7% for 32 of 48 patients who did not have HBO therapy
(Table 4). The survival difference between the HBO patients and
non-HBO patients in each subgroup such as age, location, and
severity are listed in Table 5.The septic shock survival rates were
better for patients who underwent HBO therapy than for patients
who did not undergoHBO therapy: 100% survival rate (7/7 patients)Non-HBO p* Relative ratio of survival
Survival n (%) Mortality n (%)
11 (84.62) 2 (15.38) 0.5048 1.18 (0.94e1.49)
21 (60.00) 14 (40.00) 0.2766 1.67 (1.27e2.18)
28 (75.68) 9 (24.32) 0.1709 1.32 (1.10e1.59)
4 (36.36) 7 (63.64) 0.1923 2.75 (1.26e6.01)
6 (60.00) 4 (40.00) 0.2507 1.67 (1.00e2.76)
13 (76.47) 4 (23.53) 0.5455 1.31 (1.00e1.70)
13 (61.90) 8 (38.10) 0.2689 1.62 (1.16e2.26)
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Table 6).4. Discussion
Patients with FG usually present with sudden onset and rapid
progression. It quickly spreads through the fascia to the skin and
muscle, and causes infection and necrosis of the subcutaneous
tissue. In agreement with the literature, the patients in our study
presented with redness, swelling, heat, pain (100%), and cellulitis-
like symptoms, accompanied by fever (50%) and leukocytosis
(84%). Fournier's gangrene infectious agents include mixed aerobic
and anaerobic bacteria.12 However, some patients are infected by
just one microorganism (i.e., aerobe, anaerobe, or fungus).13 Aer-
obes and anaerobes are invariably present, but anaerobes are less
frequently isolated. This low anaerobic isolation rate may be
because of a delay in the processing of specimens or because of
imprecise isolation and culture technique.13 The bacteriology
showed Enterobacter aerogene, Proteus species, and Candida infec-
tion andmortality were highly positively correlated (Table 3). Six of
our patients had ORSA. Drug resistance can admittedly lead to a
lethal outcome and is a serious problem that must be addressed.
Inmost studies, FG has a highmortality rate because of the small
number of patients and the different treatments for various types of
disease.6 Patients with FG often have one or more comorbid con-
ditions. Older age, trauma, diabetes mellitus, immunosuppression,
and chronic systemic diseases (e.g., hypertension, atherosclerosis,
and liver cirrhosis) are predisposing factors that reduce immunity
and result in uncontrolled sepsis and death.14 A poor prognosis is
associated with some risk factors such as aged older than 55 years,
diabetes, peripheral vascular disease, coronary artery disease,
ESRD, and poor nutritional status.15 In our study, mortality, co-
morbidity, and infectionwere highly positively correlated (Table 4).
There are signiﬁcant differences in the mortality rates in our study
among patients older than 55 years, or patients who had renal
disease, liver cirrhosis, complicating sepsis, and ESRD. The mor-
tality rates are not signiﬁcantly different between patients with
diabetes and hypertension; however, they were positively corre-
lated (Table 4).
According to a previous literature review, the mortality rate is
higher in patients with diffuse FG than in patients with the focal
type, especially in the lower abdomen, groin, and perineum (~28%
mortality).16 However, some studies found no relationship between
mortality and the site of infection.
The most common complications of FG include respiratory
failure, septicemia, multiple organ failure, UGI bleeding, hepatic
failure, and renal failure. In our study, 16 patients died (i.e., a
mortality rate of 26.7%). Among these patients, 14 patients died of
septicemia that led to septic shock and multiple organ failure,
which was the major cause of death; one patient died of coronary
artery disease, and one patient died of UGI bleeding that resulted
from liver cirrhosis. Fournier's gangrene is a surgical emergency.
Early diagnosis and prompt surgical debridement are the keys to
successful treatment.17,18Table 6
Analysis of the survival of septic shock.
Treatment No. of patients
(n ¼ 25)
Survival
n (%)
Mortality
n (%)
p
HBO 7 7 (100.0) 0 (0.00) 0.0007*
Non-HBO 18 4 (22.22) 14 (77.78)
*The p is from the Pearson's Chi-square test and Fisher's exact test.
HBO ¼ hyperbaric oxygen.If FG is highly suspected, surgical exploration should be per-
formed and adequate debridement is necessary. Some surgeons
suggest that routine wound management in the ﬁrst 24 hours after
debridement is necessary. If fascia necrosis spreads extensively,
redebridement should be performed immediately.19 Complicated
debridement and reconstruction of the skin defect have important
roles in treating FG. These factors present a challenge to general
surgeons, urologists, and plastic surgeons.
In this study, the patients underwent from zero to nine surgical
debridements with an average of 3.1 surgical debridements. Three
patients did not have surgical debridement because of advanced
age, rapid progress of violations, unstable condition, and malig-
nancy. After the debridement, skin and soft tissue defects may exist
that involve the penis, scrotum, perineum, lower abdomen, but-
tocks, and bilateral thighs. If the wound is too wide to stitch,
reconstruction with skin grafts and skin ﬂaps is necessary. Treat-
mentmethods depend on the severity of the disease. Among the 44
survivors, eight patients received skin ﬂaps; three patients, skin
grafts; 19 patients, wound closure; and 14 patients healed with
dressing changes.
In the postoperative period, colostomy very effectively prevents
contamination of the wound with fecal matter and enhances
wound care. The need for fecal diversion in patients with FG is
covered extensively in the published literature; however, the
timing of diversion has not been widely addressed. The reports of
factors that inﬂuence the survival of patients with FG show that the
formation of a colostomy improves the condition of the individ-
ual.20 In our study, 30 patients underwent colostomy to prevent
contamination of the wound. The survival analysis (Table 4) shows
that patients with an early colostomy had a better prognosis than
patients without a colostomy. The difference was signiﬁcant
(p < 0.001). Colostomy combined with a ﬁrst-time debridement
was reserved for patients with involvement of the anorectal region
and sphincter. Of these patients, 70.0% of patients received a co-
lostomy within 48 hours after admission and 30.0% of patients
received a delayed colostomy (i.e., >48 hours). There was a signif-
icant percentage of delayed colostomy formation in the non-
survivor group (p < 0.001). This delay appears to be primarily
associated with the presence of more extensive disease, and mor-
tality is high in this situation. Diversion colostomy decreases the
difﬁculty in nursing care, particularly in the intensive care unit
setting. With diversion colostomy, the patients could receive
nutrition via nasogastric feeding as soon as possible. Previous
research has shown the advantages of early enteral feeding.21
Our results revealed that diversion stoma plus HBO therapy has
a survival beneﬁt for patients with FG in a shock status. In addition
to the treatment regimens previously described, we also propose
the importance of adjuvant hyperbaric oxygen therapy to promote
the bactericidal effect.
Hyperbaric oxygen therapy can improve tissue perfusion, pro-
mote angiogenesis and ﬁbroblast proliferation, and increase
collagen synthesis and the oxygen level in tissues. Table 4 shows
that the patients who received HBO therapy had a signiﬁcant
improvement in survival (100%), compared to 66.7% survival for
patients who did not have HBO therapy (p ¼ 0.025, based on
Fisher's exact test).
Fournier's gangrene is a rare but rapidly progressive soft tissue
infection and is a fulminant fatal necrotizing fasciitis. It usually
occurs in combination with severe systemic toxicity. Early diag-
nosis, aggressive surgical debridement, and the use of broad-
spectrum antibiotics would reduce mortality that results from
septic shock or multiple organ failure. Bacteremia and sepsis are
major factors of morality. In the survival analysis of septic shock
(Table 6), patients with septic shock who had HBO therapy had
better survival (100%), compared to patients who did not have HBO
M.-C. Hung et al. / Urological Science 27 (2016) 148e153 153therapy (22.22% survival; p¼ 0.0007, based on Fisher's exact test). A
scoring system (i.e., FGSI) has been developed to determine the
severity of the infection and prognosis of patients with FG, based on
vital signs and laboratory data.11 In this system, the mortality rate is
75% if the FGSI score is > 9, whereas the survival rate is 78% if the
FGSI score is < 9.22 In our study, we compared the survival differ-
ence between the HBO patients and non-HBO patients in each
subgroup (i.e., age, location, and severity; Table 5). Based on the
results, there was no survival difference between the HBO and non-
HBO groups, although patients who were treated with HBO had a
higher survival rate.
This study was limited by its retrospective design, insufﬁciency
of some data within the registry, and inability to access all data. In
particular, when calculating the FGSI, some patients did not have
daily blood gas analyses data. Therefore, our FGSI values were less
than the values reported in other studies in the literature.
The results of this study showed that aggressive surgical
debridement, early colostomy, and the use of broad-spectrum an-
tibiotics can prevent substantial tissue damage and reduce
inﬂammation. If complicated by septic shock, treatment with
adjuvant hyperbaric oxygen therapy can help reduce inﬂammation,
manage sepsis, and increase survival.5. Conclusion
Fournier's gangrene requires emergency surgery. In our case
series of 60 patients, older than 55 years and the presence of un-
derlying diseases such as liver cirrhosis and ESRD were all highly
correlated with mortality. The treatment strategy includes inten-
sive hemodynamic stabilization, early diagnosis, broad-spectrum
antibiotic treatment, and aggressive extensive debridement.
Furthermore, adjuvant hyperbaric oxygen therapy can help stop the
progression of FG, prevent septic shock, and increase survival rates.Conﬂicts of interest
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